CHICAGO, July 17,
2024 /PRNewswire/ -- The global digital
pathology market is expected to grow from USD 1.1 billion in 2024 to USD 2.0 billion by 2029, at a CAGR of 13.1%. The
digital pathology market is primarily driven by the increasing
adoption of digital pathology solutions by healthcare providers and
laboratories, alongside the global expansion of telepathology
services, which improves access to expert pathology services in
remote or underserved areas. This growth is supported by
advancements in technology, including whole-slide imaging (WSI),
image analysis software, and artificial intelligence (AI), which
enhance diagnostic precision and operational efficiency. However,
integrating digital pathology systems into existing laboratory
workflows remains a challenge. The rise of AI and machine learning
applications presents significant opportunities, aiding
pathologists in identifying abnormalities and improving treatment
strategies. The market ecosystem includes entities delivering
digital pathology solutions to end users, with software being the
fastest-growing segment due to advancements in AI and machine
learning. Human pathology registers the highest growth rate driven
by the rising prevalence of chronic diseases like cancer. The drug
discovery segment accounted for the largest share in 2023,
benefiting from digital pathology's ability to analyze vast
datasets accurately. Pharmaceutical and biotechnology companies are
the largest end users, utilizing digital pathology for extensive
research and development. North
America dominates the market due to its advanced healthcare
infrastructure and significant investment in healthcare
technologies. Key market players include Fujifilm Holdings
Corporation, Danaher Corporation, Koninklijke Philips N.V., PathAI,
and F. Hoffmann-La Roche Ltd.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=844
Browse in-depth TOC on "Digital Pathology
Market"
248 - Tables
47 - Figures
325 -
Pages
DANAHER CORPORATION (US): Leader in Digital Pathology
Solutions
Danaher Corporation, through its subsidiary Leica Biosystems,
has established itself as a strong player in the digital pathology
market, offering a comprehensive portfolio from biopsy to diagnosis
across radiology, pathology, surgery, and oncology. Strategic
partnerships have significantly bolstered its market position. In
March 2023, Danaher partnered with
Paige, a global leader in digital pathology solutions and clinical
AI applications, to enhance digital pathology workflows in
hospitals and laboratories. The company also collaborates with the
European Society for Digital and Integrative Pathology (ESDIP) to
promote digital pathology adoption across Europe, fostering continuous growth and
innovation in diagnostic technologies.
KONINKLIJKE PHILIPS N.V. (Netherlands): Prominent Player in Digital
Pathology
Philips is a prominent player in the digital pathology market,
offering solutions that enhance efficiency, collaboration, and
diagnostic accuracy for pathologists globally. Philips' digital
pathology solution transitions pathologists from traditional
microscopy to digital workflows, achieving efficiency gains of
15-20% per case. By digitizing pathology processes, Philips
facilitates remote and collaborative environments, addressing the
global shortage of trained pathologists and enabling
multidisciplinary collaboration. Their solution supports remote
consultation, real-time case sharing, and multidisciplinary
discussions among clinical teams, enhancing comprehensive patient
care. With insights from over 300 customers and 20 hospital
pathology laboratories, Philips continually refines its solution to
meet diverse healthcare provider needs.
HAMAMATSU PHOTONICS K.K. (Japan): Key Player in Digital
Pathology
Hamamatsu Photonics has solidified its position in the digital
pathology market, achieving an annual growth rate of 4.4% in
medical-bio instruments from 2021 to 2023. The company's strategic
developments in expanding its digital pathology product portfolio
and significant R&D investments are set to propel its growth.
In March 2023, Hamamatsu signed a
major distribution deal with Siemens Healthineers to provide
imaging slide scanners for digital pathology in the Americas and
Europe. This partnership aims to
bridge the gap between radiology and pathology, enhancing patient
care through advanced diagnostic imaging solutions. Hamamatsu's
commitment to innovation underscores its role as a key player in
shaping the future of digital pathology.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=844
Product Segmentation: Digital Pathology Scanners Lead
The digital pathology market is divided into scanners, software,
and storage systems. In 2023, the scanner segment captured the
largest market share, driven by increasing demand for accurate and
timely diagnoses alongside a growing volume of pathology cases
worldwide. Government approvals for digital pathology scanner
systems, such as Roche's VENTANA DP 200 slide scanner, further
boost this segment's growth. Technological advancements, regulatory
support, and enhanced diagnostic capabilities are key factors
driving heavy investment and adoption of digital scanners.
Type Segmentation: Human Pathology Prevails
The market is categorized into human pathology and veterinary
pathology. In 2023, the human pathology segment dominated, fueled
by the rising prevalence of chronic diseases, cancer, and
infectious diseases globally. This segment's prominence is
attributed to its diverse diagnostic needs, the increasing burden
of diseases, the integration of AI for improved diagnostic
capabilities, and supportive regulatory frameworks that promote the
adoption of advanced digital pathology solutions.
Regional Insights: Europe Expected to Grow Rapidly
The digital pathology market is segmented into five major
regions: North America,
Europe, Asia Pacific, Latin
America, and the Middle
East and Africa.
Europe is anticipated to register
the fastest growth rate during the forecast period, driven by the
adoption of AI-based pathology tools across various NHS trusts in
the UK. Initiatives like collaborations with international firms,
including Sectra, and substantial government investments, such as
the USD 57 million allocated in 2020
for digital pathology and imaging AI, underscore Europe's commitment to enhancing healthcare
infrastructure. These efforts are expected to facilitate faster,
more accurate diagnoses through automated image analysis and
telepathology capabilities.
For more information, inquire now! Inquire Now
Related Reports:
In Vitro Diagnostics Market
Tissue Diagnostics Market
Molecular Diagnostics Market
Immunohistochemistry Market
Anatomic Pathology Market
Get access to the latest updates on Digital pathology
Companies and Digital Pathology Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/digital-pathology-market-worth-2-0-billion-by-2029-driven-by-technological-advancements--marketsandmarkets-302199113.html
SOURCE MarketsandMarkets